other material
confidence high
sentiment neutral
materiality 0.55
CNS Pharmaceuticals announces $1.98M registered direct offering and private placement
CNS Pharmaceuticals, Inc.
- Sold 1,425,000 shares at $1.39 per share with common warrants at $1.26 exercise price.
- Gross proceeds ~$1.98M; net proceeds for working capital and general corporate purposes.
- Closing expected July 5, 2024; warrants expire 5 years from issuance.
- A.G.P./Alliance Global Partners acting as financial advisor with 6.5% fee.